Coegin Pharma AB Ratios and Metrics

Market cap in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb '26 Feb 24, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	100	78	51	97	228	-
Market Cap Growth	6.58%	55.23%	-47.61%	-57.65%	-	-
Enterprise Value	92	65	44	92	197	-
Last Close Price	4.00	3.85	5.38	13.46	36.01	-
PB Ratio	8.54	3.11	7.49	4.59	11.35	-
P/TBV Ratio	12.84	4.09	-	10.46	11.35	-
Net Debt / Equity Ratio	-0.63	-0.78	-0.82	-0.18	-1.28	-1.00
Net Debt / EBITDA Ratio	0.42	0.97	0.22	0.12	0.94	0.36
Quick Ratio	3.43	11.70	0.71	0.84	2.95	7.88
Current Ratio	4.36	11.71	0.72	0.85	2.96	7.88
Return on Equity (ROE)	-	-148.58%	-201.53%	-171.54%	-147.59%	-
Return on Assets (ROA)	-	-68.67%	-77.82%	-72.78%	-68.67%	-
Return on Capital Employed (ROCE)	-178.00%	-92.40%	-412.00%	-165.10%	-135.40%	-276.90%
Earnings Yield	-20.74%	-30.30%	-55.34%	-36.52%	-11.91%	-
Buyback Yield / Dilution	-85.15%	-105.53%	-34.42%	-15.36%	-354.98%	-

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.